 Connection
Mario Enrico Canonico to Blood Platelets
This is a "connection" page, showing publications Mario Enrico Canonico has written about Blood Platelets.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.663 |
|
|
|
-
Canonico ME, Sanna GD, Siciliano R, Guarino S, Bellandi B, Scudiero F, Saba PS, Esposito G, Alexopoulos D, Parodi G. Not-high before-treatment platelet reactivity in patients with STEMI: prevalence, clinical characteristics, response to therapy and outcomes. Platelets. 2022 Apr 03; 33(3):390-397.
Score: 0.578
-
Piccolo R, Simonetti F, Avvedimento M, Cutillo M, Canonico ME, Conti V, Gargiulo G, Paolillo R, Dal Piaz F, Filippelli A, Charlier B, Spinelli A, Cristiano S, Cirillo P, Di Serafino L, Franzone A, Esposito G. Ticagrelor 60 vs. 90 mg in elderly ACS patients undergoing PCI: a randomized, crossover trial. Eur Heart J Cardiovasc Pharmacother. 2024 Nov 06; 10(7):578-587.
Score: 0.046
-
Scudiero F, Canonico ME, Sanna GD, Dossi F, Silverio A, Galasso G, Esposito G, Porto I, Parodi G. Dual Antiplatelet Therapy with 3rd Generation P2Y12 Inhibitors in STEMI Patients: Impact of Body Mass Index on Loading Dose-Response. Cardiovasc Drugs Ther. 2023 08; 37(4):695-703.
Score: 0.038
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|